Search

everythinglearnresearchcommunity

for

Search:↓

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride effectively blocks enzyme causing male pattern baldness.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Both drugs lower DHT levels, with GI198745 being more effective.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Finasteride works best in 6 months and lasts 6 years.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride may cause cataracts and floppy-iris syndrome.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Finasteride use can cause depression-like behavior in male rats.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Finasteride doesn't affect erections much, but may decrease libido in men.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride doesn't harm bone density in older men with BPH.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Post-finasteride syndrome's existence is uncertain; more research needed.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.